IBRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys Before Aug. 29th Deadline in Securities Fraud Class Action
August 28, 2023 13:31 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX CLASS ACTION REMINDER: Hagens Berman Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
July 31, 2023 11:36 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 31, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Notifies ImmunityBio (IBRX) Investors of Application Deadline in Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys
July 24, 2023 12:01 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 24, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23,...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
July 17, 2023 11:56 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 17, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX SHAREHOLDER ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending
July 12, 2023 14:08 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 12, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts ImmunityBio (IBRX) Investors to Securities Fraud Class Action, Encourages Investors with Substantial Losses to Contact Firm’s Attorneys
July 07, 2023 09:31 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 07, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May...
IBRX ALERT: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Filed
July 02, 2023 11:25 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, July 02, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Class Period: May 23, 2022...
IBRX INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations Regarding FDA Complete Response Letter
May 18, 2023 13:11 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 18, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Visit:...
IMMUNITYBIO: Kaplan Fox Investigates ImmunityBio
May 11, 2023 19:56 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of ImmunityBio, Inc. (“ImmunityBio” or the “Company”)...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ImmunityBio (IBRX) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations Regarding FDA Complete Response Letter
May 11, 2023 16:58 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 11, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges ImmunityBio, Inc. (NASDAQ: IBRX) investors who suffered substantial losses to submit your losses now. Visit:...